Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer

Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin

(2017) Alexander Bontempo et al.   ONCOLOGY REPORTS

The Role of Integrin α6 (CD49f) in Stem Cells: More than a Conserved Biomarker

(2017) Paul H. Krebsbach et al.   STEM CELLS AND DEVELOPMENT

Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1

(2016) Abhishek Tyagi et al.   CLINICAL CANCER RESEARCH

Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo

(2016) R P Hobbs et al.   ONCOGENE

Forced expression of Nanog with mRNA synthesized in vitro to evaluate the malignancy of HeLa cells through acquiring cancer stem cell phenotypes

(2016) YAN DING et al.   ONCOLOGY REPORTS

Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression

(2016) Elizabeth Ortiz-Sánchez et al.   Oncotarget

Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone

(2015) Mario Nava-Villalba et al.   Molecular Cancer

The Differential Expression of OCT4 Isoforms in Cervical Carcinoma

(2015) Shao-Wen Li et al.   PLoS One

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Cervical Cancer Cells with Positive Sox2 Expression Exhibit the Properties of Cancer Stem Cells

(2014) Xiao-Fang Liu et al.   PLoS One

6-Iodolactone, key mediator of antitumoral properties of iodine

(2014) Mario Nava-Villalba et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

The Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell Fate

(2013) Abby Sarkar et al.   Cell Stem Cell

CD49f-positive cell population efficiently enriches colon cancer-initiating cells

(2013) NAOTSUGU HARAGUCHI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

The Evolving Field of Human Papillomavirus Receptor Research: a Review of Binding and Entry

(2013) A. B. Raff et al.   JOURNAL OF VIROLOGY

OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway

(2013) Y-D Wang et al.   Cell Death & Disease

Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance

(2012) Jacqueline López et al.   BMC CANCER

The developing cancer stem-cell model: clinical challenges and opportunities

(2012) Louis Vermeulen et al.   LANCET ONCOLOGY

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

(2011) H E Lee et al.   BRITISH JOURNAL OF CANCER

Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma

(2011) Shyh-Kuan Tai et al.   CANCER SCIENCE

Inhibition of Ataxia Telangiectasia- and Rad3 -Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction

(2011) Eike Gallmeier et al.   STEM CELLS

Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma

(2009) T Noda et al.   BRITISH JOURNAL OF CANCER

Antiproliferative/Cytotoxic Activity of Molecular Iodine and Iodolactones in Various Human Carcinoma Cell Lines. No Interfering with EGF-signaling, but Evidence for Apoptosis

(2009) H. Rösner et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Reduction of CD44+/CD24− breast cancer cells by conventional cytotoxic chemotherapy

(2009) Sebastian Aulmann et al.   HUMAN PATHOLOGY

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway

(2009) M Flahaut et al.   ONCOGENE

A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplasic effect of iodine in mammary cancer

(2009) R.E. Nuñez-Anita et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Cancer Stem Cells in Solid Tumors: An Overview

(2009) Catherine Adell O'Brien et al.   SEMINARS IN RADIATION ONCOLOGY

Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects

(2008) O Arroyo-Helguera et al.   ENDOCRINE-RELATED CANCER

Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: An immunohistochemical analysis and review of the literature

(2008) Katsuhide Ikeda et al.   GYNECOLOGIC ONCOLOGY

An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

(2008) Ittai Ben-Porath et al.   NATURE GENETICS

PPAR, PTEN, and the Fight against Cancer

(2008) Rosemary E. Teresi et al.   PPAR Research